These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 20956823)
21. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives. Sakorafas GH; Tsiotou AG Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968 [TBL] [Abstract][Full Text] [Related]
22. The impact of systemic therapy following ductal carcinoma in situ. Eng-Wong J; Costantino JP; Swain SM J Natl Cancer Inst Monogr; 2010; 2010(41):200-3. PubMed ID: 20956830 [TBL] [Abstract][Full Text] [Related]
23. Can some DCIS patients avoid adjuvant therapy? Still unknown. Schmidt C J Natl Cancer Inst; 2011 Apr; 103(7):530-1. PubMed ID: 21436062 [No Abstract] [Full Text] [Related]
24. Multidisciplinary Shared Decision Making in the Management of Ductal Carcinoma In Situ of the Breast. Parikh P; Pockaj B; Wasif N; Halyard M; Wong W; Kosiorek HE; Dueck AC; Gray R Ann Surg Oncol; 2015 Dec; 22 Suppl 3(0 3):S516-21. PubMed ID: 25986869 [TBL] [Abstract][Full Text] [Related]
25. Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast. Ringberg A; Idvall I; Fernö M; Anderson H; Anagnostaki L; Boiesen P; Bondesson L; Holm E; Johansson S; Lindholm K; Ljungberg O; Ostberg G Eur J Surg Oncol; 2000 Aug; 26(5):444-51. PubMed ID: 11016463 [TBL] [Abstract][Full Text] [Related]
26. Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy. Rodrigues N; Carter D; Dillon D; Parisot N; Choi DH; Haffty BG Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1331-5. PubMed ID: 12459354 [TBL] [Abstract][Full Text] [Related]
27. A Quantitative Centrosomal Amplification Score Predicts Local Recurrence of Ductal Carcinoma Mittal K; Toss MS; Wei G; Kaur J; Choi DH; Melton BD; Osan RM; Miligy IM; Green AR; Janssen EAM; Søiland H; Gogineni K; Manne U; Rida P; Rakha EA; Aneja R Clin Cancer Res; 2020 Jun; 26(12):2898-2907. PubMed ID: 31937618 [TBL] [Abstract][Full Text] [Related]
28. Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects. Mokbel K Int J Fertil Womens Med; 2003; 48(5):217-25. PubMed ID: 14626378 [TBL] [Abstract][Full Text] [Related]
29. San Antonio Breast Cancer Symposium explores DCIS "battleground". Gottlieb N J Natl Cancer Inst; 2000 Feb; 92(4):295-7. PubMed ID: 10675372 [No Abstract] [Full Text] [Related]
30. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast. Solin LJ; Fourquet A; Vicini FA; Haffty B; Taylor M; McCormick B; McNeese M; Pierce LJ; Landmann C; Olivotto IA; Borger J; de La Rochefordiere A; Schultz DJ Cancer; 2001 Mar; 91(6):1090-7. PubMed ID: 11267953 [TBL] [Abstract][Full Text] [Related]
32. Molecular markers for the diagnosis and management of ductal carcinoma in situ. Polyak K J Natl Cancer Inst Monogr; 2010; 2010(41):210-3. PubMed ID: 20956832 [TBL] [Abstract][Full Text] [Related]
33. Contralateral breast cancer risk and endocrine therapy use in patients with ductal carcinoma in situ treated with unilateral mastectomy in the modern era. ElSherif AS; Tu C; Valente SA Am J Surg; 2021 Mar; 221(3):521-524. PubMed ID: 33189311 [TBL] [Abstract][Full Text] [Related]
34. Adjuvant radiation therapy in small ductal carcinoma in situ. Cho WK; Choi DH; Kim H; Noh JM; Park W; Cha H Breast; 2019 Feb; 43():55-58. PubMed ID: 30448710 [TBL] [Abstract][Full Text] [Related]
35. Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting. Habel LA; Achacoso NS; Haque R; Nekhlyudov L; Fletcher SW; Schnitt SJ; Collins LC; Geiger AM; Puligandla B; Acton L; Quesenberry CP Breast Cancer Res; 2009; 11(6):R85. PubMed ID: 19922614 [TBL] [Abstract][Full Text] [Related]
36. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Fisher B; Land S; Mamounas E; Dignam J; Fisher ER; Wolmark N Semin Oncol; 2001 Aug; 28(4):400-18. PubMed ID: 11498833 [TBL] [Abstract][Full Text] [Related]
37. Ductal carcinoma in situ (DCIS) of the breast: diagnostic and therapeutic controversies. Silverstein MJ; Parker R; Grotting JC; Cote RJ; Russell CA J Am Coll Surg; 2001 Feb; 192(2):196-214. PubMed ID: 11220720 [No Abstract] [Full Text] [Related]
38. Breast carcinoma in sclerosing adenosis: a clinicopathological and immunophenotypical analysis on 206 lesions. Yu BH; Tang SX; Xu XL; Cheng YF; Bi R; Shui RH; Tu XY; Lu HF; Zhou XY; Yang WT J Clin Pathol; 2018 Jun; 71(6):546-553. PubMed ID: 29436376 [TBL] [Abstract][Full Text] [Related]
39. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Freedman G; Fowble B; Hanlon A; Nicolaou N; Fein D; Hoffman J; Sigurdson E; Boraas M; Goldstein L Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1005-15. PubMed ID: 10421533 [TBL] [Abstract][Full Text] [Related]